| PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease B Zheng, Z Liao, JJ Locascio, KA Lesniak, SS Roderick, ML Watt, ... Science translational medicine 2 (52), 52ra73-52ra73, 2010 | 807 | 2010 |
| Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease DM Maraganore, M De Andrade, A Elbaz, MJ Farrer, JP Ioannidis, ... Jama 296 (6), 661-670, 2006 | 585 | 2006 |
| Technology in Parkinson's disease: challenges and opportunities AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ... Movement Disorders 31 (9), 1272-1282, 2016 | 504 | 2016 |
| A genomic pathway approach to a complex disease: axon guidance and Parkinson disease TG Lesnick, S Papapetropoulos, DC Mash, J Ffrench-Mullen, L Shehadeh, ... PLoS genetics 3 (6), e98, 2007 | 422 | 2007 |
| Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease J Pablo, SA Banack, PA Cox, TE Johnson, S Papapetropoulos, ... Acta Neurologica Scandinavica 120 (4), 216-225, 2009 | 353 | 2009 |
| Psychiatric comorbidities of episodic and chronic migraine DC Buse, SD Silberstein, AN Manack, S Papapetropoulos, RB Lipton Journal of neurology 260, 1960-1969, 2013 | 340 | 2013 |
| Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial AA Argyriou, E Chroni, A Koutras, J Ellul, S Papapetropoulos, G Katsoulas, ... Neurology 64 (1), 26-31, 2005 | 300 | 2005 |
| Peripheral nerve damage associated with administration of taxanes in patients with cancer AA Argyriou, M Koltzenburg, P Polychronopoulos, S Papapetropoulos, ... Critical reviews in oncology/hematology 66 (3), 218-228, 2008 | 290 | 2008 |
| Lrrk2 and Lewy body disease OA Ross, M Toft, AJ Whittle, JL Johnson, S Papapetropoulos, DC Mash, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 277 | 2006 |
| Drug repurposing from the perspective of pharmaceutical companies Y Cha, T Erez, IJ Reynolds, D Kumar, J Ross, G Koytiger, R Kusko, ... British journal of pharmacology 175 (2), 168-180, 2018 | 264 | 2018 |
| Psychotic symptoms in Parkinson’s disease: from description to etiology S Papapetropoulos, DC Mash Journal of neurology 252, 753-764, 2005 | 161 | 2005 |
| A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results AA Argyriou, E Chroni, A Koutras, G Iconomou, S Papapetropoulos, ... Supportive Care in Cancer 14, 1134-1140, 2006 | 160 | 2006 |
| Melatonin MT1 and MT2 receptor expression in Parkinson's disease. N Adi, DC Mash, Y Ali, C Singer, L Shehadeh, S Papapetropoulos Medical science monitor: international medical journal of experimental and …, 2010 | 155 | 2010 |
| Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation AA Argyriou, E Chroni, A Koutras, G Iconomou, S Papapetropoulos, ... Journal of pain and symptom management 32 (3), 237-244, 2006 | 153 | 2006 |
| Descriptive epidemiology of cervical dystonia G Defazio, J Jankovic, JL Giel, S Papapetropoulos Tremor and Other Hyperkinetic Movements 3, 2013 | 137 | 2013 |
| Patient diaries as a clinical endpoint in Parkinson's disease clinical trials S Papapetropoulos CNS neuroscience & therapeutics 18 (5), 380-387, 2012 | 129 | 2012 |
| Post‐stroke spasticity: Predictors of early development and considerations for therapeutic intervention J Wissel, M Verrier, DM Simpson, D Charles, P Guinto, ... PM&R 7 (1), 60-67, 2015 | 127 | 2015 |
| SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease LA Shehadeh, K Yu, L Wang, A Guevara, C Singer, J Vance, ... PloS one 5 (2), e9104, 2010 | 114 | 2010 |
| Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations S Papapetropoulos, DS McCorquodale, J Gonzalez, L Jean-Gilles, ... Parkinsonism & related disorders 12 (4), 253-256, 2006 | 111 | 2006 |
| A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease S Papapetropoulos, H Katzen, A Schrag, C Singer, BK Scanlon, D Nation, ... BMC neurology 8, 1-8, 2008 | 104 | 2008 |
